# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Pablo Neruda (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML051-SYN
- Date: 2026-06-01
- Fictional facility: St. Posthumous Health Center
- Fictional author: Marisol Fairweather-Diaz, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for new patient with four months of urinary symptoms and six weeks of right hip and low back pain: examination, PSA and baseline tests, pain control, the staging and biopsy plan, and medical oncology referral. **S**

## Objective

PSA: 46.8 ng/mL (high); Total testosterone: 468 ng/dL; Hemoglobin: 13.6 g/dL; White cell count: 6.4 10*3/uL; Platelets: 248 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.3 mmol/L; Glucose: 104 mg/dL (high); Creatinine: 0.96 mg/dL; eGFR (CKD-EPI 2021): 87 mL/min/1.73 m²; Calcium: 9.6 mg/dL; ALT: 22 U/L; AST: 24 U/L; Alkaline phosphatase: 168 U/L (high); Albumin: 4.1 g/dL; LDH: 208 U/L; Hemoglobin A1c: 5.9% (high); Total cholesterol: 214 mg/dL (high); HDL cholesterol: 46 mg/dL; LDL cholesterol: 140 mg/dL (high); Triglycerides: 140 mg/dL; 25-hydroxyvitamin D: 22 ng/mL (low); PHQ-9: 6; IPSS total (0 to 35): 17; Pain, 0 to 10: 6. All results are synthetic.

BP 146/88 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 92.4 kg; BMI 29.2 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Urinary frequency, weak stream and nocturia for four months, with right hip and low back pain for six weeks, a hard nodular prostate and a raised PSA; suspected prostate cancer, to be confirmed; Essential hypertension for five years, on amlodipine; Prediabetes (hemoglobin A1c 5.9%). Strengths and supports remain part of the care plan. **S**

## Medication changes

- Continued without change: Amlodipine 5 mg oral tablet, one tablet daily **S**
- Started: Acetaminophen 500 mg oral tablet, two tablets (1000 mg) up to three times daily as needed for bone pain **S**

## Plan

- Medical oncology (genitourinary) consultation within two weeks for suspected metastatic prostate cancer: diagnosis, staging, systemic treatment, radiotherapy, bone health and genetic testing. Guideline: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (2026); Advanced Prostate Cancer: AUA/SUO Guideline, first published 2020 and amended 2023 and 2026 (2026) **S**
- Diagnosis and staging: multiparametric MRI of the prostate, an MRI-targeted transperineal biopsy at the urology practice, CT of the chest, abdomen and pelvis, a bone scan, and PSMA PET/CT. Guideline: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (2026); Advanced Prostate Cancer: AUA/SUO Guideline, first published 2020 and amended 2023 and 2026 (2026); CMID: Clinical Monitoring Intelligence Database, prostate cancer and hypertension monographs (2026) **S**
- Bone pain: acetaminophen 1000 mg up to three times a day; spinal cord compression warning signs explained in Spanish, with same-day assessment for new leg weakness or numbness, or loss of bladder or bowel control. Guideline: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (2026) **S**
- Care in Spanish, his first language: a professional medical interpreter for every major discussion, written plans in Spanish, appointments placed around his morning writing and his official duties. Guideline: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (2026) **S**
